Serum Soluble CD163 and Interleukin-6 Levels in Women with Ovarian Endometriomas
Authors:
- Chang Suk SuhCSChang Suk Suh
- Seok Hyun KimSKSeok Hyun Kim
- Shin Yong MoonSMShin Yong Moon
- 3 March 2008
- journal article
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 66 (1) , 47-52
Abstract
Background: CD163 is a hemoglobin scavenger receptor exclusively expressed in the monocyte-macrophage system and its soluble form (sCD163) has not yet been studied as a serum marker in women with endometriosis. The purpose of this study was to evaluate whether serum levels of sCD163 and interleukin-6 (IL-6) could be possible markers for ovarian endometriomas discriminating adnexal benign cystic tumors. Methods: The concentrations of sCD163 and IL-6 were determined using commercial ELISA kits in frozen sera collected from 95 women prior to surgery for adnexal benign cystic tumors: 44 with ovarian endometriomas, 24 with mature cystic teratomas, 10 with mucinous cystadenomas, 8 with serous cystadenomas and 9 with parovarian cysts. Serum levels of CA-125 were also recorded preoperatively. The volume of cysts was evaluated in women with ovarian endometriomas. Results: The serum levels of sCD163 and IL-6 were not significantly different among the women with various adnexal benign cystic tumors. In patients with endometriomas (n = 44), the levels were similar to those with nonendometriotic benign cystic tumors (n = 51): 3,431.7 ± 343.9 vs. 3,231.0 ± 391.7 ng/ml for sCD163 and 5.3 ± 0.9 vs. 12.9 ± 4.0 pg/ml for IL-6 (mean ± SEM). No correlation was noted between serum levels of two markers with volume of endometriomas. Conclusion: Our findings suggest that serum levels of sCD163 as well as IL-6 are not useful markers for ovarian endometriomas.Keywords
This publication has 35 references indexed in Scilit:
- Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal TimingCancer Research, 2010
- Quantification of Circadian Rhythms in Single CellsPLOS Computational Biology, 2009
- A model of the cell-autonomous mammalian circadian clockProceedings of the National Academy of Sciences, 2009
- Human peritoneal macrophages show functional characteristics of M‐CSF‐driven anti‐inflammatory type 2 macrophagesEuropean Journal of Immunology, 2007
- Gates and Oscillators II: Zeitgebers and the Network Model of the Brain ClockJournal of Biological Rhythms, 2007
- Suppression of Matrix Metalloproteinase-9 by Prostaglandin E2 in Peritoneal Macrophage Is Associated with Severity of EndometriosisThe American Journal of Pathology, 2005
- Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levelsCytometry Part B: Clinical Cytometry, 2004
- Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis*Critical Care Medicine, 2002
- Soluble CD163: a marker molecule for monocyte/macrophage activity in diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2002
- The melatonin rhythm: both a clock and a calendarCellular and Molecular Life Sciences, 1993